FDA head calls for probe into Alzheimer’s drug review

9July 2021

The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug

Leave a Reply

Your email address will not be published.

See Your Business Here!

For more information on our listings, advertising, coupons, and mailers, please contact us today!